ACTRN12616000886482.

Study name	Randomised trial aiming to prevent development of depression and improve quality of life in individuals with dementia (Alzheimer’s disease) through a novel Cognitive Bias Modification intervention
Methods	blinded randomised controlled trial
Participants	target size: 300
Interventions	cognitive bias modification (CBM)
Outcomes	primary: Incidence of clinically significant depressive symptoms in adults with Alzheimer's disease measured by the Cornell Scale for Depression in Dementia (CSDD).
Starting date	2016‐07‐06
Contact information	andrew.ford@uwa.edu.au; varsha,hirani@uwa.edu.au
Notes	This study is led by Dr. Andrew Ford (principal investigator) in Australia (ACTRN12616000886482). Dr. Ford was contacted in March 2020: the trial is still ongoing.